Brief: Harrow Launches Ilevro, Nevanac, And Maxidex In The U.S.
02/05/2023 12:19
May 2 (Reuters) - Harrow Health Inc HROW.O :
* HARROW LAUNCHES ILEVRO®, NEVANAC®, AND MAXIDEX® IN THE
U.S.
Source text for Eikon: ID:nBwHhwy8a
Further company coverage: HROW.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates